Remdesivir is no Ram Baan against virus

Docs, officials advise against crazy run for the injection

It is essential to remove misconception among the people that Remdesivir is a life-saver anti-viral drug, said Nashik district collector Suraj Mandhare and IMA
NASHIK, Apr 25 (The CONNECT) - Even as the WHO said there is currently no evidence that Remdesivir improves survival and other outcomes in COVID patients, the Indian Medical Association and Nashik district collector issued guidelines stating that the injection is no Ram Baan.
“It is essential to remove misconception among the people that Remdesivir is a life-saver anti-viral drug,” said Nashik district collector Suraj Mandhare. This misconception is making the near and dear of patients exert pressure on doctors to give the injection. The IMA too shared similar advice, basis the COVID task force recommendations.
The injection has to be given strictly only on medical advice and hence the patients should leave it to the judgement of doctors. At best, Remdesivir helps cut down hospital stay by a couple of days as it might help in checking the multiplication of the virus in a patient’s body.
It should not  be given to patients in home isolation and they can be saved even without the injection, the collector’s note to hospitals said.
Meanwhile, Principal Scientific Advisor K Vijay Raghavan has said that Remdesivir should be taken only on medical advice, according to All India Radio.
In a tweet, Raghavan said, the drug does not cure COVID-19, it can only reduce hospital stay by a few days. He urged people to listen to their doctor, and do not force them to prescribe Remdesivir.
The Who said Work on remdesivir began on 15 October when the WHO Solidarity Trial published its interim results. 
The evidence suggested no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes.
The guideline development group recognized that more research is needed, especially to provide higher certainty of evidence for specific groups of patients. 

Recent News